Company: NIVFW
Filing Date: 2025-05-29
Form Type: F-1/A
Source: 0001213900-25-048554
Chunk: 75

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-29
Form: F-1/A
Chunk 75
---
 impacted directly                                                                                     
 and indirectly by certain fraud and abuse laws, including the Act Supplementing the Constitution Relating to the Prevention and Suppression  
 of Corruption B.E. 2561 (2018) of Thailand, the Penal Code of Thailand, the Criminal Code of Cambodia, the Offences Code of                  
 October 28, 2021 No. 128 of Kyrgyzstan, the Criminal Code of October 28, 2021, No. 17 of Kyrgyzstan and the Law on prevention                
 of corruption of August 8, 2021 No. 153 of Kyrgyzstan. Because the solutions and services NewGenIvf provides are not reimbursed              
 by government healthcare payors, such fraud and abuse laws generally do not directly apply to its business, however, some laws may           
 be applicable. The laws, regulations and other requirements in this area are both broad and vague and judicial interpretation can            
 also be inconsistent. NewGenIvf reviews its practices with regulatory experts in an effort to comply with all applicable laws, regulatory    
 and other requirements. However, NewGenIvf is unable to predict how these laws, regulations and other requirements will be interpreted       
 or the full extent of their application, particularly to services that are not directly reimbursed by healthcare programs. Any determination 
 by a regulatory authority that any of NewGenIvf’s activities or those of its clients or vendors violate any of these laws or                 
 regulations could subject NewGenIvf to civil or criminal penalties, require it to enter into corporate integrity agreements or similar       
 agreements with ongoing compliance obligations, disqualify it from providing services to clients and/or have an adverse impact on            
 its business, financial condition and results of operations. Even an unsuccessful challenge by a regulatory authority of NewGenIvf’s         
 activities could result in adverse publicity and could require a costly response from it.                                                    |

| ● | Consumer Protection Laws. Consumer protection laws are                                                                                   
 being applied increasingly by the Office of the Consumer Protection Board in Thailand and by the Cambodia Ministry of Health to regulate 
 the collection, use, storage and disclosure of personal or health information, through websites or otherwise, and, in Cambodia, by       
 the Consumer Protection Competition and Fraud Repression Directorate-General, to regulate the presentation of website content. Courts    
 may also adopt the standards for fair information practices, which concern consumer notice, choice, security and access.                 |

| ● | Restrictions on Communication. Communications with NewGenIvf’s                                                                       
 clients increasingly may be subject to and restricted by laws and